4.7 Article

Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up

Journal

ANNALS OF ONCOLOGY
Volume 25, Issue -, Pages 40-48

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/annonc/mdu223

Keywords

-

Categories

Funding

  1. Pierre Fabre
  2. Pierre Fabre Oncology
  3. Amgen
  4. Astellas
  5. Bayer
  6. Celgene
  7. Dendreon
  8. Ferring
  9. GlaxoSmithKline
  10. Janssen Cilag
  11. Novartis
  12. Pfizer
  13. Roche
  14. Sanofi
  15. Shionogi
  16. Takeda
  17. Teva/Oncogenex

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available